Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry
Bone Marrow Transplantation, 08/08/2012
Martino M et al. – The findings suggest that could be a role for high–dose chemotherapy (HDC) and autologous hematopoietic SCT (AHSCT) in delaying disease progression and possibly cure a subset of metastatic breast cancer (MBC) patient harboring chemosensitive tumors.



